3164
vs
T
Taiwan Weighted Index
3164
Over the past 12 months, GenMont Biotech Inc has underperformed Taiwan Weighted Index, delivering a return of -22% compared to the Taiwan Weighted Index's +51% growth.
Stocks Performance
3164 vs Taiwan Weighted Index
Performance Gap
3164 vs Taiwan Weighted Index
Performance By Year
3164 vs Taiwan Weighted Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
GenMont Biotech Inc
Glance View
Genmont Biotech Inc. engages in the research of new functional bacteria as well as the manufacturing and sale of probiotic powder. The company is headquartered in Tainan, Tainan. The company went IPO on 2003-06-12. The firm's major products include lactobacillus paracasei, lactobacillus rhamnosus, lactobacillus casei, lactobacillus plantarum, lactobacillus fermentum, lactobacillus salivarius, lactobacillus acidophilus, lactobacillus reuteri, lactobacillus brevis, lactobacillus bulgaricus, lactobacillus gasseri, lactobacillus johnsonii and others. The Company’s products are applied to enhance human immunity against dust allergy and digestive system health care. The firm distributes its products in domestic market and to overseas markets.
